Estrogen replacement therapy is not conducive of venous thromboembolism

Maturitas

Volumn 13, Issue 3, 1991, Pages 189-192

  Young, R L ^a   Goepfert, A R ^a   Goldzieher, H W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Estrogen; Hypercoagulability; Menopause; Thromboembolism; Thrombosis

Indexed keywords

ESTROGEN;

ADULT; AGED; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; THROMBOEMBOLISM;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; THROMBOPHLEBITIS;

EID: 0025914772     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(91)90193-T     Document Type: Article

References (29)

1. Estrogen replacement therapy
2. Estrogen replacement therapy
3. The menopause
4. Estrogen replacement in the menopause
5. Surgically confirmed gallbladder disease, venous thromboembolism and breast tumors in relation to postmenopausal estrogen therapy
6. Risk of vascular disease in women
7. Effects of long-term estrogen replacement therapy. 1. Metabolic effects
8. Estrogen replacement therapy II
9. Advantages and risks of estrogen therapy in the menopause
10. Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies
11. Erroneous clinical diagnosis of leg vein thrombosis in women on oral contraceptive
12. Effects of 'natural oestrogen' replacement on menopausal symptoms and blood clotting
13. Coagulation system changes in post-menopausal women receiving oestrogen preparations
14. Conjugated equine oestrogens and blood clotting: a follow-up report
15. Effect of conjugated equine estrogens on serum lipids and the clotting mechanism
16. Coagulation studies of menopausal women taking estrogen replacement
17. The effect of natural oestrogens on coagulation
18. The effect of oestradiol valerate therapy on coagulation factors and lipid and oestrogen levels in oophorectomized women
19. A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women
20. Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women
21. Conjugated estrogens and hypercoagulability
22. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation
23. Natural estrogen and antithrombin III activity in postmenopausal women
24. The effects of oestrogen administration on the plasma free protein S and C4b-binding protein
25. A comparison of the effects of two triphasic oral contraceptives on haemostasis
26. The effect of conjugated estrogens on coagulability in menopausal women
27. Noncontraceptive estrogen use and cardiovascular disease
28. Epidemiologic studies of hemostasis in OC users
29. Thromboembolism and the pill: sense and nonsense in conclusions based on analogy